chemoradiotherapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

chemoradiotherapy
Jan 7, 2025, 18:38 | Insight
Concomitant PPIs and capecitabine-based chemoradiotherapy in rectal cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a…
Jan 6, 2025, 14:37 | Science
Felipe Couñago: Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients
Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a recent article on X: "Our…
Dec 27, 2024, 16:29 | Blog
Drew Moghanaki: The PACIFIC-5 study results are finally available
Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA,…
Dec 19, 2024, 02:54 | Blog
Bladder-Sparing Strategies for MIBC: Insights from Professor Ming Cao at ESMO Asia2024
Mediamedic shared a post on LinkedIn: "Bladder-Sparing Strategies for MIBC: Insights from Professor Ming Cao at…
Dec 8, 2024, 04:47 | Insight
Exciting developments in the management of unresectable stage III EGFR NSCLC
Aakash Desai, Assistant Professor and Associate Director at UAB O'Neal Comprehensive Cancer Center, shared an…
Dec 3, 2024, 09:23 | Blog
Adding preoperative chemoradiotherapy for gastric cancer shows no survival benefit - EORTC
EORTC - European Organisation for Research and Treatment of Cancer posted the following on LinkedIn:…
Nov 14, 2024, 13:35 | Insight
Adding CXB to Chemoradiotherapy in early Rectal Adenocarcinoma significantly improves outcomes
Iván R. González, Medical Oncologist at the Comprehensive Oncology Center, Ángeles Hospital Puebla, shared an…
Oct 26, 2024, 10:57 | Blog
Is CRT no longer a component of multidisciplinary care for gastric cancer?
Erman Akkus, Medical Oncology fellow at the Ankara University, Faculty of Medicine, shared a recent…
Oct 20, 2024, 19:15 | Insight
Gustavo Viani: Osimertinib post-CRT as the standard of care in unresectable stage III EGFR mutated NSCLC
Gustavo Viani, Associate Professor in the Department of Medical Imaging, Hematology, and Oncology at Hospital…
Oct 20, 2024, 11:34 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Oct 2, 2024, 13:22 | Blog
The results of the TOPGEAR trial on gastric and GEJ adenocarcinoma - EORTC
EORTC (European Organisation for Research and Treatment of Cancer) shared a post on LinkedIn: ''We’re…
Sep 27, 2024, 16:51 | Blog
Aren Karapetyan: New study on nasopharyngeal carcinoma shows improved outcomes with Nedaplatin
Aren Karapetyan, Oncology Resident at Yerevan State Medical University, shared the following on LinkedIn: “New study…
Sep 24, 2024, 11:46 | Blog
David Palma: Final results of ORATOR, after completion of the full follow-up period
David Palma shared a post on X, about recent paper published in Journal of Clinical…
Sep 24, 2024, 08:51 | Insight
Aren Karapetyan: New Insights on Treatment for Squamous Cell Carcinoma of the Anus
Aren Karapetyan, Oncology Resident at Yerevan State Medical University, shared a post on LinkedIn: "New…
Sep 19, 2024, 08:35 | Insight
Iván R. González: Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:…
Aug 28, 2024, 03:51 | Insight
Article of the day, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: "Article of the day! Suggest by…
Aug 25, 2024, 02:22 | Blog
First patient dosed in the UK with a new lung cancer vaccine - Oncogene Cancer Research
Oncogene Cancer Research shared a post on LinkedIn: "Big news out today in the UK:…
Aug 12, 2024, 21:46 | Blog
GI cancers - rapid oral abstracs in ASCOBT 24 summarized by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X: "GI…
Jul 7, 2024, 07:19 | Insight
Adjuvant GemCis vs CRT with capecitabine in gallbladder cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Adjuvant GemCis (gemcitabine and cisplatin)…
Jun 26, 2024, 12:05 | Insight
Piotr Wysocki: Osimertinib after radiochemotherapy improves PFS in EGFR-mutated NSCLC patients – but is it really what they need?
Piotr Wysocki recently posted on LinkedIn: "The results of the LAURA study were presented during a…
May 12, 2024, 07:27 | Drugs
Tanja Obradovic summarizes the latest news on immunotherapy with chemoradiation NSCLC
Tanja Obradovic, Vice President of  Oncology Scientific Affairs at ICON, shared on LinkedIn: “Based on what…
Apr 19, 2024, 06:19 | Insight
Sergio Cifuentes Canaval: I'm thrilled to share groundbreaking progress in the treatment of locally advanced cervical cancer (LACC)!
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared on LinkedIn: "I'm thrilled to…
Apr 8, 2024, 16:20 | Drugs
Rami Manochakian: BIG NEWS press release by AstraZeneca!
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: “Hot Off…
Apr 8, 2024, 14:26 | Insight
Shubh Goel: ADRIATIC Phase III trial for LS-SCLC couldn’t come at a more critical time for patients
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a post…
Apr 5, 2024, 01:51 | Insight
Piotr J. Wysocki: Pembrolizumab significantly improves efficacy of chemoradiotherapy in patients with locally-advanced cervical cancer
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
All: 25 Posts: 1 - 100
Special Coverage